IBRN vs. IBIT
IBRN (iShares Neuroscience and Healthcare ETF) and IBIT (iShares Bitcoin Trust ETF) are both exchange-traded funds - IBRN is a Health & Biotech Equities fund tracking the NYSE FactSet Global Neuro Biopharma and MedTech Index, while IBIT is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant. Both are passively managed. Over the past year, IBRN returned 52.57% vs -35.90% for IBIT. At a 0.34 correlation, their price movements are largely independent. IBRN charges 0.47%/yr vs 0.25%/yr for IBIT.
Performance
IBRN vs. IBIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRN achieves a 4.62% return, which is significantly higher than IBIT's -23.36% return.
IBRN
- 1D
- -4.52%
- 1M
- -1.90%
- YTD
- 4.62%
- 6M
- 12.73%
- 1Y
- 52.57%
- 3Y*
- 11.10%
- 5Y*
- —
- 10Y*
- —
IBIT
- 1D
- -6.03%
- 1M
- -14.44%
- YTD
- -23.36%
- 6M
- -26.36%
- 1Y
- -35.90%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IBRN vs. IBIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 4.62% | 28.49% | -1.58% |
IBIT iShares Bitcoin Trust ETF | -23.36% | -6.41% | 99.21% |
Correlation
The correlation between IBRN and IBIT is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Jan 12, 2024 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRN vs. IBIT — Risk / Return Rank
IBRN
IBIT
IBRN vs. IBIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and iShares Bitcoin Trust ETF (IBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBRN | IBIT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.09 | -0.83 | +2.91 |
Sortino ratioReturn per unit of downside risk | 2.94 | -1.09 | +4.03 |
Omega ratioGain probability vs. loss probability | 1.34 | 0.88 | +0.46 |
Calmar ratioReturn relative to maximum drawdown | 6.30 | -0.73 | +7.03 |
Martin ratioReturn relative to average drawdown | 15.59 | -1.27 | +16.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBRN | IBIT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.09 | -0.83 | +2.91 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.32 | +0.04 |
Drawdowns
IBRN vs. IBIT - Drawdown Comparison
The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum IBIT drawdown of -49.36%. Use the drawdown chart below to compare losses from any high point for IBRN and IBIT.
Loading charts...
Drawdown Indicators
| IBRN | IBIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.38% | -49.36% | +13.98% |
Max Drawdown (1Y)Largest decline over 1 year | -8.80% | -49.36% | +40.56% |
Max Drawdown (3Y)Largest decline over 3 years | -35.38% | — | — |
Current DrawdownCurrent decline from peak | -6.28% | -46.63% | +40.35% |
Average DrawdownAverage peak-to-trough decline | -9.83% | -15.96% | +6.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.56% | 28.28% | -24.72% |
Volatility
IBRN vs. IBIT - Volatility Comparison
The current volatility for iShares Neuroscience and Healthcare ETF (IBRN) is 7.66%, while iShares Bitcoin Trust ETF (IBIT) has a volatility of 9.76%. This indicates that IBRN experiences smaller price fluctuations and is considered to be less risky than IBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRN | IBIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.66% | 9.76% | -2.10% |
Volatility (6M)Calculated over the trailing 6-month period | 19.29% | 34.85% | -15.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.38% | 43.65% | -18.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.32% | 50.20% | -24.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.32% | 50.20% | -24.88% |
IBRN vs. IBIT - Expense Ratio Comparison
IBRN has a 0.47% expense ratio, which is higher than IBIT's 0.25% expense ratio.
Dividends
IBRN vs. IBIT - Dividend Comparison
IBRN's dividend yield for the trailing twelve months is around 0.95%, while IBIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
IBIT iShares Bitcoin Trust ETF | 0.00% | 0.00% | 0.00% | 0.00% |
IBRN iShares Neuroscience and Healthcare ETF | 0.95% | 0.99% | 0.40% | 0.06% |
Frequently Asked Questions
IBRN and IBIT have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBIT has higher volatility (9.76%) compared to IBRN (7.66%). In terms of maximum drawdown, IBRN dropped -35.38% vs IBIT's -49.36%.
On 1-year performance, IBRN leads with 52.57% vs -35.90% for IBIT. On fees, IBIT is cheaper at 0.25% per year. On volatility, IBRN has been the lower-risk option at 7.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IBRN has performed better with a 52.57% return vs -35.90%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBIT is cheaper with a 0.25% expense ratio, compared with 0.47% for IBRN.
IBRN has the higher dividend yield at 0.95%, compared with 0.00% for IBIT.
IBRN is categorized as Health & Biotech Equities, while IBIT is Cryptocurrency. IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while IBIT tracks CME CF Bitcoin Reference Rate - New York Variant. Their fees differ too: 0.47% for IBRN and 0.25% for IBIT.
IBRN currently has the higher Sharpe Ratio (2.09 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRN and IBIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer